Understanding how genetic information is read and translated may be about to undergo a significant conceptual upgrade. Beyond the familiar sequence of A, U, G, and C bases, RNA molecules fold into elaborate three-dimensional architectures — hairpins, pseudoknots, G-quadruplexes — and these shapes appear to function as a largely underappreciated layer of biological control. The implications for designing next-generation medicines targeting everything from cancer to neurodegeneration are substantial.
This review in Acta Pharmacologica Sinica synthesizes emerging evidence that RNA structural elements directly govern core gene expression processes: transcription, splicing, translation initiation, and mRNA stability. The authors detail how specific folded motifs serve as docking platforms for RNA-binding proteins and small molecules, effectively acting as molecular switches that turn gene programs on or off. Critically, they examine how this structural code is being decoded through advances in chemical probing technologies — SHAPE-MaP, DMS-MaPseq — and cryo-EM, which now allow near-atomic resolution mapping of RNA conformations inside living cells. The review further catalogues therapeutic candidates that exploit these structures, including small molecules that selectively bind pathological RNA folds implicated in myotonic dystrophy, spinal muscular atrophy, and certain oncogenic transcripts.
For the broader field of precision medicine, this framing matters because sequence-based targeting alone has repeatedly encountered resistance and off-target effects. RNA structure adds a second combinatorial dimension to drug design — two molecules with identical sequences can fold differently depending on cellular context, creating tissue-specific or disease-specific targets. The limitation here is that RNA structures are dynamic and context-dependent, making high-throughput therapeutic targeting still largely preclinical. This is a confirmatory and synthetic review rather than a single breakthrough experiment, consolidating a fast-moving field into a practical roadmap. For health-conscious adults, the near-term relevance lies in understanding why RNA medicines — already exemplified by mRNA vaccines — represent a genuinely expandable platform whose sophistication is still early-stage.